| |
| |
|
| Insider
Information: |
Bradbury Daniel |
| Relationship: |
Director |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
8 |
|
| Direct
Shares |
232,105 |
|
|
Indirect Shares
|
3,161,475 |
|
|
| Direct
Value |
$2,471,016 |
|
|
|
Indirect Value
|
$4,283,565 |
|
|
| Total
Shares |
3,393,580 |
|
|
| Total
Value |
$6,754,581 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Amylin Pharmaceuticals Inc |
AMLN |
President & Chief Exec... |
2012-08-08 |
0 |
2012-08-08 |
0 |
Premium* |
|
|
Paratek Pharmaceuticals Inc |
PRTK |
Director |
2006-05-09 |
35,714 |
|
0 |
Premium* |
|
|
Illumina Inc |
ILMN |
Director |
2017-05-25 |
15,324 |
2008-05-16 |
0 |
Premium* |
|
|
Corcept Therapeutics Inc |
CORT |
Director |
2012-11-21 |
0 |
2019-02-07 |
130,575 |
Premium* |
|
|
Geron Corporation |
GERN |
Director |
2014-05-09 |
142,776 |
2019-03-29 |
51,323 |
Premium* |
|
|
Equillium Inc |
EQ |
Chief Executive Office... |
2018-10-16 |
0 |
2018-10-16 |
2,969,596 |
Premium* |
|
|
Castle Biosciences Inc |
CSTL |
Director |
2024-05-25 |
13,291 |
2024-05-06 |
9,981 |
Premium* |
|
|
Nuvation Bio Ord Shs Class A |
NUVB |
Director |
2021-02-10 |
25,000 |
2021-02-10 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
424 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 8 of 17
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AMLN |
Amylin Pharmaceuticals In... |
officerTitle |
• – – |
2006-02-07 |
4 |
AS |
$38.00 |
$76,000 |
D/D |
(2,000) |
25,268 |
|
- |
|
| ILMN |
Illumina Inc |
Director |
– • – |
2014-06-12 |
4 |
OE |
$36.29 |
$76,209 |
D/D |
2,100 |
14,566 |
0 |
- |
|
| ILMN |
Illumina Inc |
Director |
– • – |
2014-06-27 |
4 |
OE |
$36.29 |
$76,209 |
D/D |
2,100 |
14,566 |
0 |
- |
|
| ILMN |
Illumina Inc |
Director |
– • – |
2014-07-08 |
4 |
OE |
$36.29 |
$76,209 |
D/D |
2,100 |
14,566 |
0 |
- |
|
| ILMN |
Illumina Inc |
Director |
– • – |
2014-07-23 |
4 |
OE |
$36.29 |
$76,209 |
D/D |
2,100 |
14,566 |
0 |
- |
|
| ILMN |
Illumina Inc |
Director |
– • – |
2014-08-04 |
4 |
OE |
$36.29 |
$76,209 |
D/D |
2,100 |
14,566 |
0 |
- |
|
| ILMN |
Illumina Inc |
Director |
– • – |
2014-08-22 |
4 |
OE |
$36.29 |
$76,209 |
D/D |
2,100 |
14,566 |
0 |
- |
|
| ILMN |
Illumina Inc |
Director |
– • – |
2014-05-27 |
4 |
OE |
$36.29 |
$77,349 |
D/D |
2,100 |
11,624 |
0 |
- |
|
| ILMN |
Illumina Inc |
Director |
– • – |
2010-12-14 |
4 |
OE |
$39.14 |
$78,280 |
D/D |
2,000 |
3,800 |
0 |
- |
|
| ILMN |
Illumina Inc |
Director |
• • – |
2017-01-04 |
4 |
AS |
$133.93 |
$81,008 |
D/D |
(600) |
16,465 |
0 |
- |
|
| ILMN |
Illumina Inc |
Director |
• • – |
2016-11-14 |
4 |
AS |
$136.34 |
$81,803 |
D/D |
(600) |
16,465 |
0 |
- |
|
| ILMN |
Illumina Inc |
Director |
– • – |
2014-03-06 |
4 |
OE |
$39.14 |
$82,194 |
D/D |
2,100 |
12,024 |
0 |
- |
|
| ILMN |
Illumina Inc |
Director |
– • – |
2014-03-19 |
4 |
OE |
$39.14 |
$82,194 |
D/D |
2,100 |
12,024 |
0 |
- |
|
| ILMN |
Illumina Inc |
Director |
– • – |
2014-04-04 |
4 |
OE |
$39.14 |
$82,194 |
D/D |
2,100 |
12,024 |
0 |
- |
|
| ILMN |
Illumina Inc |
Director |
– • – |
2014-04-15 |
4 |
OE |
$39.14 |
$82,194 |
D/D |
2,100 |
12,024 |
0 |
- |
|
| ILMN |
Illumina Inc |
Director |
– • – |
2014-05-02 |
4 |
OE |
$39.14 |
$82,194 |
D/D |
2,100 |
12,024 |
0 |
- |
|
| ILMN |
Illumina Inc |
Director |
– • – |
2014-05-14 |
4 |
OE |
$39.14 |
$82,194 |
D/D |
2,100 |
12,024 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
Chief Operating Officer |
• – – |
2006-03-07 |
4 |
AS |
$42.50 |
$85,000 |
D/D |
(2,000) |
24,600 |
|
- |
|
| ILMN |
Illumina Inc |
Director |
– • – |
2010-11-02 |
4 |
OE |
$13.30 |
$85,120 |
D/D |
6,400 |
8,337 |
0 |
- |
|
| ILMN |
Illumina Inc |
Director |
– • – |
2010-12-09 |
4 |
OE |
$13.30 |
$85,120 |
D/D |
6,400 |
1,900 |
0 |
- |
|
| ILMN |
Illumina Inc |
Director |
– • – |
2014-09-03 |
4 |
OE |
$36.29 |
$85,351 |
D/D |
2,100 |
13,866 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
officerTitle |
• – – |
2006-01-09 |
4 |
AS |
$43.00 |
$86,000 |
D/D |
(2,000) |
27,268 |
|
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2023-12-04 |
4 |
AS |
$20.08 |
$87,165 |
I/I |
(4,340) |
53,042 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2022-01-18 |
4 |
AS |
$35.07 |
$87,201 |
I/I |
(2,470) |
125,651 |
0 |
- |
|
| ILMN |
Illumina Inc |
Director |
– • – |
2011-05-18 |
4 |
OE |
$17.58 |
$87,875 |
D/D |
5,000 |
6,740 |
0 |
- |
|
424 Records found
|
|
Page 8 of 17 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
